Fingerprint
Dive into the research topics of 'The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer
D. C. Smith, K. J. Pienta
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations